Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients

Summary

The purpose of this study is to determine whether standard medications approved for Alzheimer's disease treatment differ in their action on brain functioning and whether any observed brain activity differences as result of treatment are associated with particular patterns of dementia improvement or reduced decline.

Timeline

Start

2006-10

Primary completion

2007-10

Completion

2007-11

Outcome

Outcome not reported

Stopped: “Reduced access to AchEI medication-naive mild AD patients.”

Drugs

Indications